Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleAbbVie Announces Late Breaking Data at AAN to Support Atogepant Long-Term Safety, Efficacy for Migraine Prevention.AuthorsHalsey, GraceSubjectsMEDICAL research; MIGRAINE preventionPublicationPatient Care (Online), 2024, p1ISSN1939-1897Publication typeArticle